Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 3—March 2013

Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection

Max R. O’DonnellComments to Author , Nesri Padayatchi, Charlotte Kvasnovsky, Lise Werner, Iqbal Master, and C. Robert Horsburgh
Author affiliations: Author affiliations: Albert Einstein College of Medicine, Bronx, New York, USA (M.R. O’Donnell); Centre for AIDS Programme of Research in South Africa, Durban, South Africa (M.R. O’Donnell, N. Padayatchi, L. Werner); University of Maryland School of Medicine, Baltimore, Maryland, USA (C. Kvasnovsky); King George V Hospital, Sydenham, South Africa (I. Master); Boston University School of Public Health, Boston, Massachusetts, USA (C.R. Horsburgh, Jr.); Boston University School of Medicine, Boston (C.R. Horsburgh, Jr.)

Main Article

Table 6

Sputum culture conversion at intervals of survival for XDR TB patients, KwaZulu-Natal Province, South Africa*

Time from start of treatment, mo No. cultures converted /total (%) No. cultures converted/ total converted (%) Sensitivity, % Specificity, % Positive predictive value, % Negative predictive value, %
1 4/114 (4) 4/42 (10) 12 99 75 79
2 18/114 (16) 18/42 (43) 42 92 61 84
3 29/114 (25) 29/42 (69) 65 86 59 89
4 33/114 (29) 33/42 (79) 77 85 61 93
6 39/114 (34) 39/42 (93) 92 83 62 97
24 42/114 (37) NA NA NA NA NA

*XDR TB, extensively drug-resistant tuberculosis; NA, not applicable.

Main Article

Page created: March 21, 2013
Page updated: March 21, 2013
Page reviewed: March 21, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.